Balance sheet components - Accrued expenses and other current liabilities (Details) - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Balance sheet components | ||
| Clinical development expenses | $ 12,048 | $ 7,036 |
| Manufacturing expenses | 7,133 | 9,462 |
| Compensation and related benefits | 6,168 | 11,527 |
| Development milestones | 986 | 10,000 |
| Operating lease liabilities, current portion | 152 | 0 |
| Other | 3,230 | 3,626 |
| Total accrued expenses and other current liabilities | $ 29,717 | $ 41,651 |
| X | ||||||||||
- Definition Accrued clinical development expenses. No definition available.
|
| X | ||||||||||
- Definition Accrued development milestones. No definition available.
|
| X | ||||||||||
- Definition Accrued manufacturing expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other. No definition available.
|
| X | ||||||||||
- Definition Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|